Amgen call volume above normal and directionally bullish

3 days ago · Bullish option flow detected in Amgen (AMGN) with 8,403 calls trading, 2x expected, and implied vol increasing over 3 points to 49.64%. Jan-25 295 calls and Jan-27 300 calls are the most active ...

CouponFollow Extension

64%
OFF

Amgen Call Volume Above Normal And Directionally Bullish

1 week from now

nasdaq.com

64%
OFF

Amgen Call Volume Above Normal And Directionally Bullish

1 week from now

4 days ago · Bullish option flow detected in Amgen (AMGN) with 8,403 calls trading, 2x expected, and implied vol increasing over 3 points to 49.64%. ... Amgen call volume above normal and …

businessinsider.com

$329
OFF

Balanced Outlook For Amgen: Growth Potential Amidst Challenges …

1 week from now

Feb 25, 2024 · Amgen call volume above normal and directionally bullish Amgen downgraded, Enphase upgraded: Wall Street’s top analyst calls Amgen price target raised to $329 from …

businessinsider.com

68%
OFF

Energy Fuels Call Volume Above Normal And Directionally Bullish

1 week from now

2 days ago · Bullish option flow detected in Energy Fuels (UUUU) with 10,214 calls trading, 2x expected, and implied vol increasing almost 6 points to 68.68%. Nov-24 7 calls and Nov-24 6 …

nasdaq.com

20%
OFF

Blue Owl Capital Call Volume Above Normal And Directionally

1 week from now

2 days ago · Bullish option flow detected in Blue Owl Capital (OWL) with 2,840 calls trading, 1.5x expected, and implied vol increasing almost 4 points to 38.20%. Dec-24 24 calls and Jan-26 …

nasdaq.com

32%
OFF

Iris Energy Call Volume Above Normal And Directionally Bullish

1 week from now

3 days ago · Bullish option flow detected in Iris Energy (IREN) with 53,154 calls trading, 4x expected, and implied vol increasing almost 5 points to 128.32%. Dec-24 25 calls and Jan-25 …

businessinsider.com

28%
OFF

Eli Lilly Call Volume Above Normal And Directionally Bullish

1 week from now

Nov 11, 2024 · Bullish option flow detected in Eli Lilly (LLY) with 38,006 calls trading, 1.2x expected, and implied vol increasing over 1 point to 32.28%. Nov-24 700 calls and Nov-24 815 …

nasdaq.com

70%
OFF

SoundHound AI Call Volume Above Normal And Directionally Bullish …

1 week from now

Oct 28, 2024 · Bullish option flow detected in SoundHound (SOUN) AI with 46,059 calls trading, 3x expected, and implied vol increasing over 5 points to 83.70%. 11/8 weekly 6.5 calls and …

nasdaq.com

60%
OFF

Nu Holdings Call Volume Above Normal And Directionally Bullish

1 week from now

Oct 29, 2024 · Bullish option flow detected in Nu Holdings (NU) with 39,471 calls trading, 1.5x expected, and implied vol increasing over 1 point to 50.60%. Dec-24 16 calls and Nov-24 10 …

nasdaq.com

52%
OFF

Charles Schwab Call Volume Above Normal And Directionally Bullish …

1 week from now

4 days ago · Bullish option flow detected in Charles Schwab (SCHW) with 38,699 calls trading, 5x expected, and implied vol increasing almost 2 points to 27.52%. Nov-24 80 calls and Nov-24 …

nasdaq.com

35%
OFF

Iovance Biotherapeutics Call Volume Above Normal And …

1 week from now

3 days ago · Bullish option flow detected in Iovance Biotherapeutics with 13,526 calls trading, 1.3x expected, and implied vol increasing over 11 points to 119.35%.Mar-25 20 calls and Dec-24 9 …

businessinsider.com

35%
OFF

Iovance Biotherapeutics Call Volume Above Normal And ... - Nasdaq

1 week from now

Bullish option flow detected in Iovance Biotherapeutics (IOVA) with 13,526 calls trading, 1.3x expected, and implied vol increasing over 11 points to 119.35%. Mar-25 20 calls and Dec-24 9 …

nasdaq.com

21%
OFF

Zoom Video Communications Call Volume Above Normal And

1 week from now

Oct 22, 2024 · Bullish option flow detected in Zoom Video (ZM) Communications with 7,771 calls trading, 1.2x expected, and implied vol increasing over 2 points to 33.21%. 10/25 weekly 73 …

nasdaq.com

65%
OFF

TG Therapeutics Call Volume Above Normal And Directionally …

1 week from now

Nov 5, 2024 · Bullish option flow detected in TG Therapeutics (TGTX) with 2,340 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 62.65%. Dec-24 28 calls and Nov …

nasdaq.com

FAQs about Amgen call volume above normal and directionally bullish Coupon?

Should you buy Amgen (AMGN) stock?

DBS analyst Nico Chen has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due to a combination of factors including Amgen’s consistent performance in launching blockbuster drugs and positive clinical trial data, as well as strategic mergers and acquisitions. ...

Did Amgen stock pull back to a 320-day moving average?

Specifically, Amgen stock pulled back to within one standard deviation of its 320-day moving average during yesterday's negative price action. Per Schaeffer's Senior Quantitative Analyst Rocky White, AMGN has run into this trendline six times in the last three years. ...

Why has David Risinger rated Amgen (Amgen) a hold?

David Risinger has given his Hold rating due to a combination of factors surrounding Amgen’s rare disease portfolio and its future prospects. Risinger acknowledges the potential for growth in Amgen’s product line, particularly with the recent acquisition of Horizon Therapeutics. ...

Why are Amgen shares attempting to bounce back?

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday, following reports that the company’s weight-loss drug, MariTide, triggers a significant loss in bone density. Last seen holding above $300, AMGN could be due for more chart recovery if past is precedent. ...

Why has Nico Chen rated Amgen (Amgen) a buy?

Nico Chen has given his Buy rating due to a combination of factors including Amgen’s consistent performance in launching blockbuster drugs and positive clinical trial data, as well as strategic mergers and acquisitions. Amgen’s track record since 2018 indicates that such events have historically led to significant share price increases. ...

Who is Amgen (AMGN)?

Begin your TipRanks Premium journey today. Amgen (AMGN) Company Description: Founded in 1980, California-based Amgen, Inc. is one of the world’s leading biotechnology companies, which is engaged in the discovery, development, manufacture and marketing of human therapeutics. ...